CN101260152A - 负调节Osteoprotegerin配体活性的方法 - Google Patents
负调节Osteoprotegerin配体活性的方法 Download PDFInfo
- Publication number
- CN101260152A CN101260152A CNA2007101927772A CN200710192777A CN101260152A CN 101260152 A CN101260152 A CN 101260152A CN A2007101927772 A CNA2007101927772 A CN A2007101927772A CN 200710192777 A CN200710192777 A CN 200710192777A CN 101260152 A CN101260152 A CN 101260152A
- Authority
- CN
- China
- Prior art keywords
- opgl
- ser
- leu
- gly
- ala
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199801164 | 1998-09-15 | ||
DKPA199801164 | 1998-09-15 | ||
US60/102,896 | 1998-10-02 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN99810872A Division CN1318105A (zh) | 1998-09-15 | 1999-09-13 | 负调节Osteoprotegerin配体活性的方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101260152A true CN101260152A (zh) | 2008-09-10 |
Family
ID=27675500
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007101927772A Pending CN101260152A (zh) | 1998-09-15 | 1999-09-13 | 负调节Osteoprotegerin配体活性的方法 |
Country Status (4)
Country | Link |
---|---|
CN (1) | CN101260152A (sh) |
EA (1) | EA006940B1 (sh) |
RS (1) | RS49960B (sh) |
ZA (1) | ZA200102131B (sh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019061297A1 (zh) * | 2017-09-29 | 2019-04-04 | 苏州工业园区唯可达生物科技有限公司 | 一种cd4辅助性t细胞表位融合肽及其疫苗 |
CN110923266A (zh) * | 2019-11-07 | 2020-03-27 | 苏州工业园区唯可达生物科技有限公司 | 一种重组病毒载体、包含其的免疫组合物以及用途 |
-
1999
- 1999-09-13 CN CNA2007101927772A patent/CN101260152A/zh active Pending
- 1999-09-13 EA EA200100356A patent/EA006940B1/ru not_active IP Right Cessation
- 1999-09-13 RS YUP-197/01A patent/RS49960B/sr unknown
-
2001
- 2001-03-14 ZA ZA200102131A patent/ZA200102131B/en unknown
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019061297A1 (zh) * | 2017-09-29 | 2019-04-04 | 苏州工业园区唯可达生物科技有限公司 | 一种cd4辅助性t细胞表位融合肽及其疫苗 |
CN109575142A (zh) * | 2017-09-29 | 2019-04-05 | 苏州工业园区唯可达生物科技有限公司 | 一种cd4辅助性t细胞表位融合肽及其疫苗 |
CN109575142B (zh) * | 2017-09-29 | 2022-07-12 | 苏州工业园区唯可达生物科技有限公司 | 一种cd4辅助性t细胞表位融合肽及其疫苗 |
CN110923266A (zh) * | 2019-11-07 | 2020-03-27 | 苏州工业园区唯可达生物科技有限公司 | 一种重组病毒载体、包含其的免疫组合物以及用途 |
Also Published As
Publication number | Publication date |
---|---|
RS49960B (sr) | 2008-09-29 |
YU19701A (sh) | 2005-06-10 |
ZA200102131B (en) | 2002-06-14 |
EA006940B1 (ru) | 2006-06-30 |
EA200100356A1 (ru) | 2001-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6645500B1 (en) | Method for down-regulating osteoprotegerin ligand activity | |
US7070784B1 (en) | Method for down-regulating GDF-8 activity using immunogenic GDF-8 analogues | |
CA2687533C (en) | Immunological methods to modulate myostatin in vertebrate subjects | |
JP4446601B2 (ja) | B群連鎖球菌の糖質を免疫学的に模倣する抗イディオタイプ抗体を含むワクチン処方物 | |
TW510921B (en) | Modified TNFα molecules, DNA encoding such modified TNFα molecules and vaccines comprising such modified TNFα molecules and DNA | |
CZ168296A3 (en) | Spermatic antigen corresponding to auto-antigenic epitope of spermatic bond protein | |
US5098998A (en) | Cholera vaccines and peptides | |
US20080253993A1 (en) | Immunogenic Egfr Peptides Comprising Foreign T Cell Stimulating Epitope | |
CA2467052A1 (en) | Immunogenic mimetics of multimer proteins with promiscuous t cell epitope inserts | |
CN1639569B (zh) | 诱导免疫应答的方法和组合物 | |
US5330753A (en) | Cholera vaccines | |
CN101260152A (zh) | 负调节Osteoprotegerin配体活性的方法 | |
MXPA02006313A (es) | Vacunacion de acido nucleico. | |
US20060222624A1 (en) | Detoxified TNF and method of preparing | |
US20060013822A1 (en) | Utilization of mhc class II binding motifs in immunization to produce immune, serum, monoclonal antibodies and vaccines | |
HALKIER et al. | Sommaire du brevet 2343654 | |
HALKIER et al. | Patent 2343654 Summary | |
EP1541587A2 (en) | Method for down-regulating osteoprotegerin ligand activity | |
MXPA00008032A (en) | Immunological methods to modulate myostatin in vertebrate subjects |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20080910 |